• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强蛋白质递送的策略。

Strategies to Enhance Protein Delivery.

作者信息

Zhu Yucheng, Zhuang Weisi, Cheng Hao

机构信息

Department of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania 19104, United States.

出版信息

Langmuir. 2025 Mar 18;41(10):6457-6470. doi: 10.1021/acs.langmuir.4c04636. Epub 2025 Mar 7.

DOI:10.1021/acs.langmuir.4c04636
PMID:40052814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11924232/
Abstract

Therapeutic proteins play a crucial role in modern healthcare. However, the rapid clearance of proteins in the circulation system poses a significant threat to their therapeutic efficacy. The generation of anti-drug antibodies expedites drug clearance, resulting in another challenge to overcome in protein delivery. Several methods to increase the circulation half-lives of these proteins and to minimize their immunogenicity have been developed. This Review discusses the causes of protein clearance in the body, evaluates the FDA-approved strategies to prolong protein circulation, and highlights recent progress in the field. Additionally, the strengths and drawbacks of these methods and our perspectives for advancing protein delivery are provided.

摘要

治疗性蛋白质在现代医疗保健中发挥着至关重要的作用。然而,蛋白质在循环系统中的快速清除对其治疗效果构成了重大威胁。抗药物抗体的产生加速了药物清除,这成为蛋白质递送中另一个需要克服的挑战。已经开发了几种方法来延长这些蛋白质的循环半衰期并使其免疫原性最小化。本综述讨论了体内蛋白质清除的原因,评估了美国食品药品监督管理局(FDA)批准的延长蛋白质循环的策略,并强调了该领域的最新进展。此外,还介绍了这些方法的优缺点以及我们对推进蛋白质递送的展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/c4c30b3c0f91/la4c04636_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/f502b5bc266a/la4c04636_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/a59a2d7f287b/la4c04636_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/ee959cfd0a9a/la4c04636_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/dbf76c7e61cc/la4c04636_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/35c3354dd859/la4c04636_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/6e50ab06b48e/la4c04636_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/816a40b617b2/la4c04636_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/c4c30b3c0f91/la4c04636_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/f502b5bc266a/la4c04636_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/a59a2d7f287b/la4c04636_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/ee959cfd0a9a/la4c04636_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/dbf76c7e61cc/la4c04636_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/35c3354dd859/la4c04636_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/6e50ab06b48e/la4c04636_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/816a40b617b2/la4c04636_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e345/11924232/c4c30b3c0f91/la4c04636_0008.jpg

相似文献

1
Strategies to Enhance Protein Delivery.增强蛋白质递送的策略。
Langmuir. 2025 Mar 18;41(10):6457-6470. doi: 10.1021/acs.langmuir.4c04636. Epub 2025 Mar 7.
2
Challenges and Therapeutic Approaches for the Protein Delivery System: A Review.蛋白质递送系统的挑战与治疗方法:综述
Pharm Nanotechnol. 2024;12(5):391-411. doi: 10.2174/0122117385265979231115074255.
3
Nanotechnology for protein delivery: Overview and perspectives.用于蛋白质递送的纳米技术:概述与展望。
J Control Release. 2016 Oct 28;240:24-37. doi: 10.1016/j.jconrel.2015.10.012. Epub 2015 Oct 13.
4
PEGylation, successful approach to drug delivery.聚乙二醇化,一种成功的药物递送方法。
Drug Discov Today. 2005 Nov 1;10(21):1451-8. doi: 10.1016/S1359-6446(05)03575-0.
5
Role of Nanotechnology in Delivery of Protein and Peptide Drugs.纳米技术在蛋白质和肽类药物递送中的作用。
Curr Pharm Des. 2015;21(29):4155-73. doi: 10.2174/1381612821666150901095722.
6
PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.蛋白质和脂质体的聚乙二醇化:一种强大而灵活的改善药物传递的策略。
Curr Drug Metab. 2012 Jan;13(1):105-19. doi: 10.2174/138920012798356934.
7
Virus-like particle encapsulation of functional proteins: advances and applications.功能性蛋白质的病毒样颗粒封装:进展与应用
Theranostics. 2024 Nov 4;14(19):7604-7622. doi: 10.7150/thno.103127. eCollection 2024.
8
Surface modified proteins and peptides for targeted drug delivery.用于靶向药物递送的表面修饰蛋白质和肽。
Prog Mol Biol Transl Sci. 2025;212:389-438. doi: 10.1016/bs.pmbts.2024.12.001. Epub 2025 Jan 27.
9
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders.当前用于治疗脑部疾病的治疗性蛋白和酶的递药策略。
Int Rev Neurobiol. 2017;137:1-28. doi: 10.1016/bs.irn.2017.08.006. Epub 2017 Oct 16.
10
Microspheres and microcapsules for protein delivery: strategies of drug activity retention.用于蛋白质递药的微球和微囊:药物活性保留策略。
Curr Pharm Des. 2013;19(35):6340-52. doi: 10.2174/1381612811319350010.

本文引用的文献

1
Glycosylation: mechanisms, biological functions and clinical implications.糖基化:机制、生物学功能和临床意义。
Signal Transduct Target Ther. 2024 Aug 5;9(1):194. doi: 10.1038/s41392-024-01886-1.
2
GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs.GP60和SPARC作为白蛋白受体:抗肿瘤药物递送的关键靶点
Front Pharmacol. 2024 Jan 23;15:1329636. doi: 10.3389/fphar.2024.1329636. eCollection 2024.
3
PEGylated therapeutics in the clinic.临床中的聚乙二醇化治疗药物。
Bioeng Transl Med. 2023 Sep 22;9(1):e10600. doi: 10.1002/btm2.10600. eCollection 2024 Jan.
4
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications.GIPR/GLP-1R 双重激动剂治疗糖尿病和体重减轻:化学、生理学和临床应用。
Cell Metab. 2023 Sep 5;35(9):1519-1529. doi: 10.1016/j.cmet.2023.07.010. Epub 2023 Aug 16.
5
Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy.提高肿瘤内 IL12 免疫细胞因子的穿透性可增强抗肿瘤疗效。
Front Immunol. 2022 Oct 27;13:1034774. doi: 10.3389/fimmu.2022.1034774. eCollection 2022.
6
A Reactive Oxygen Species-Scavenging 'Stealth' Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors.一种具有清除活性氧物种功能的“隐形”聚合物——聚(硫代缩水甘油基甘油),在蛋白质缀合物和纳米载体中优于聚乙二醇,并增强蛋白质对环境和生物胁迫的稳定性。
J Am Chem Soc. 2022 Nov 23;144(46):21304-21317. doi: 10.1021/jacs.2c09232. Epub 2022 Nov 11.
7
Zwitterionic Biomaterials.两性离子生物材料
Chem Rev. 2022 Dec 14;122(23):17073-17154. doi: 10.1021/acs.chemrev.2c00344. Epub 2022 Oct 6.
8
Tirzepatide: First Approval.替尔泊肽:首次获批
Drugs. 2022 Jul;82(11):1213-1220. doi: 10.1007/s40265-022-01746-8.
9
Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.定制组合脂质纳米颗粒用于核酸、蛋白质和药物的细胞内递送。
Acta Pharm Sin B. 2022 Jun;12(6):2624-2639. doi: 10.1016/j.apsb.2022.04.013. Epub 2022 Apr 27.
10
Cytochrome P450 Enzymes and Drug Metabolism in Humans.细胞色素 P450 酶与人体药物代谢。
Int J Mol Sci. 2021 Nov 26;22(23):12808. doi: 10.3390/ijms222312808.